Valuation: Hypha Labs, Inc.

Market Cap 738K 649K 612K 558K 1.04M 70.8M 1.05M 7.34M 2.84M 36.03M 2.77M 2.71M 117M P/E 2024
-3.73x
P/E 2025 -0.99x
Enterprise Value 2.35M 2.06M 1.95M 1.77M 3.32M 225M 3.34M 23.34M 9.05M 115M 8.81M 8.62M 373M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
79.16%
Yield 2024 *
-
Yield 2025 -
1 day-16.18%
1 week+130.30%
Current month+91.60%
1 month+46.15%
3 months-11.63%
6 months-50.43%
Current year-71.50%
1 week 0
Extreme 0.0042
0.01
1 month 0
Extreme 0.0023
0.01
Current year 0
Extreme 0.0023
0.04
1 year 0
Extreme 0.0023
0.04
3 years 0
Extreme 0.0023
0.07
5 years 0
Extreme 0.0011
0.07
10 years 0
Extreme 0.0011
0.59
Manager TitleAgeSince
Chief Executive Officer 78 29/02/2024
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer 75 29/04/2024
Director TitleAgeSince
Director/Board Member 70 25/09/2019
Chairman 78 21/10/2021
Date Insider Type Main position Quantity % Market Cap. Importance
18/1/23 Free

Chief Executive Officer

6,000,000 7.9844%
21/10/21 Free

Chief Executive Officer

1,500,000 2.1058%
1/7/21 Other

Chief Executive Officer

808,824 1.1863%
Change 5-day change 1-year change 3-year change Capi.($)
-16.18%+130.30%-54.58%-43.00% 738K
+0.53%+1.96%-13.25%-0.09% 7.37B
+0.77%+3.25%-28.32%-34.61% 1.4B
-2.77%-1.58%-42.12%-42.77% 1.03B
-3.01%+22.26%-39.66%+54.33% 950M
+0.87%-3.48%-18.87%-32.69% 742M
-0.38%-0.09%-38.69%-46.74% 729M
+5.26%+15.70%+22.27%+94.44% 725M
-1.16%+0.10%-20.89%-48.21% 619M
+1.30%-0.55%-12.94%+50.97% 619M
Average -1.44%+0.84%-24.70%-4.84% 1.42B
Weighted average by Cap. +0.45%+0.39%-18.71%-2.10%

Financials

2024 2025
Net sales - -
Net income -785K -691K -651K -594K -1.11M -75.4M -1.12M -7.82M -3.03M -38.37M -2.95M -2.88M -125M -3.1M -2.73M -2.57M -2.35M -4.39M -298M -4.42M -30.87M -11.96M -152M -11.65M -11.39M -493M
Net Debt 1.05M 924K 871K 795K 1.49M 101M 1.5M 10.45M 4.05M 51.31M 3.94M 3.86M 167M 1.61M 1.41M 1.33M 1.22M 2.28M 154M 2.29M 16M 6.2M 78.57M 6.04M 5.91M 256M
Logo Hypha Labs, Inc.
Hypha Labs, Inc., through its wholly owned subsidiary, Hypha Products Inc., is engaged in the research, development and commercialization of a bioreactor, the Hypha Micropearl bioreactor. The Hypha Micropearl bioreactor is a home appliance designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. The Company’s device, together with its replacement cartridges, produces enriched mycelium of functional mushrooms, or Micropearls, in eight days. These Micropearls contain active mushroom ingredients that offer a way to harness the medicinal properties of fungi in a concentrated easy to handle tasteless and odorless form. These Micropearls can be incorporated into various food and beverages without altering the flavor. The QR codes on the cartridges are scanned to the Hypha Lab app and inserted into the device and the Micropearls are produced and fully formed in eight days. Its Hypha Micropearl bioreactor is to be sold with replaceable cartridges.
Employees
5
Date Price Change Volume
23/09/26 USD 0.004500 +2.27% 231,200
22/09/26 USD 0.004400 -7.95% 2,527
21/09/26 USD 0.004780 -4.40% 40,065
18/09/26 USD 0.005000 +1.01% 30,000
16/09/26 USD 0.004950 -17.50% 290,039
  1. Stock Market
  2. Stocks
  3. FUNI Stock